Brief: Evolent Health - Reaffirms 2025 Revenue Guidance Of $2.06 Bln To $2.11 Bln - SEC Filing
03/06/2025 12:02
June 3 (Reuters) - Evolent Health Inc EVH.N: REAFFIRMS 2025 REVENUE GUIDANCE OF $2.06 BILLION TO $2.11 BILLION - SEC FILING REAFFIRMS Q2 2025 REVENUE GUIDANCE OF $440 MILLION TO $470 MILLION - SEC FILING FY2025 REVENUE VIEW $2.05 BILLION -- LSEG IBES DATA Q2 REVENUE VIEW $459.4 MILLION -- LSEG IBES DATA Source text: [ID:n0001628908-25-000069] Further company coverage: EVH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows